Moderna (MRNA) financial statements

+1693.4%since 2016
FY2025 revenue
$1.9B▼ −39.9%
FY2025 net income
−$2.8B
FY2025 diluted EPS
−$7.26
FY2025 free cash flow
−$2.1B

Moderna income statement

Moderna income statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Revenue1,9443,2366,848
Operating income-3,074-3,945-4,239
Pretax income-2,768-3,607-3,942
Net income-2,822-3,561-4,714
Diluted earnings per share-7.26-9.28-12.33

Moderna balance sheet

Moderna balance sheet
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Cash and cash equivalents (derived)2,5951,9292,907
Total assets12,33814,14218,426
Total liabilities3,6883,2414,572
Total equity8,65010,90113,854
Long-term debt5900n/a

Moderna cash flow statement

Moderna cash flow statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Operating cash flow-1,873-3,004-3,118
Capital expenditure-192-1,051-707
Free cash flow (derived)-2,065-4,055-3,825
Share repurchases-20-1,153

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended30 Sep 202630 Jun 202631 Mar 202631 Dec 2025
Revenue (derived)1,313145389678
Operating income (derived)130-815-1,388-857
Net income (derived)162-782-1,343-826
Diluted earnings per share0.38-1.97-3.40n/a
Operating cash flow (derived)-1,559-526-630930
Total assets13,46810,96111,48812,338

Moderna major shareholders

Moderna major shareholders
HolderShare of classSharesFiled
Abigail P. Johnson14.8%58,929,9485 November 2026
FMR LLC14.8%58,929,9485 November 2026
Vanguard Capital Management6.5%25,933,82430 April 2026
Capital World Investors5.6%22,276,99613 August 2026

Moderna 10-K and SEC filings

Moderna 10-K and SEC filings
FiledFormTypeDescription
16 November 20268-KCurrent reportCurrent report
13 November 20268-KCurrent reportCurrent report
6 November 202610-QQuarterly reportQuarterly report
6 November 20268-KCurrent reportCurrent report
30 September 20268-KCurrent reportCurrent report
1 September 20268-KCurrent reportCurrent report
31 July 202610-QQuarterly reportQuarterly report
31 July 20268-KCurrent reportCurrent report

Common questions

What was Moderna's revenue in fiscal 2025?

Moderna reported $1.9 billion in revenue for fiscal 2025, the year ended 31 December 2025, down 39.9% from fiscal 2024.

What was Moderna's net income in fiscal 2025?

Moderna reported a net loss of $2.8 billion for fiscal 2025, the year ended 31 December 2025. Diluted earnings per share were −$7.26.

What was Moderna's free cash flow in fiscal 2025?

Moderna had negative free cash flow of $2.1 billion in fiscal 2025. Operating cash flow was -$1.9 billion and capital expenditure was $192 million.

What were Moderna's total assets at the end of fiscal 2025?

Moderna reported total assets of $12.3 billion at the end of fiscal 2025, the year ended 31 December 2025.

How much Moderna history do I get?

Every account gets the full history, annual and quarterly, with first reported values and as of dates.